John G. Ullman & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$4.36M |
| 2 |
Lindsay Corp
LNN
|
+$2.93M |
| 3 |
BCE
BCE
|
+$2.52M |
| 4 |
Eversource Energy
ES
|
+$2.24M |
| 5 |
Manhattan Associates
MANH
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$9.71M |
| 2 |
Lumentum
LITE
|
+$8.2M |
| 3 |
Broadcom
AVGO
|
+$6.96M |
| 4 |
IBM
IBM
|
+$5.79M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.58% |
| 2 | Industrials | 16.51% |
| 3 | Utilities | 15.6% |
| 4 | Healthcare | 10.18% |
| 5 | Energy | 5.24% |
Similar funds
John G. Ullman & Associates's Q4 2025 Portfolio in Review
As of Q4 2025, John G. Ullman & Associates held 184 positions worth $750M, up 0.98% from $743M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
John G. Ullman & Associates withdrew a net $29.9M in Q4 2025, closing 5 positions and reducing 92 holdings. Its most notable exit was Baxter International, an estimated $1.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Industrials and Utilities.
Against the trend, John G. Ullman & Associates opened a new position in Keurig Dr Pepper worth $4.44M.
- John G. Ullman & Associates's largest Q4 2025 buy was Keurig Dr Pepper: 158,600 shares worth $4.44M.
- John G. Ullman & Associates added most to Lindsay Corp in Q4 2025, an estimated $2.93M increase.
- John G. Ullman & Associates's biggest Q4 2025 reduction was Bloom Energy, cutting an estimated $9.71M.
- John G. Ullman & Associates fully exited Baxter International in Q4 2025, selling an estimated $1.2M.
- John G. Ullman & Associates's ten largest holdings make up 33% of its $750M portfolio in Q4 2025.
- John G. Ullman & Associates opened 11 new positions and closed 5 in Q4 2025.
- John G. Ullman & Associates's portfolio value rose 0.98% quarter-over-quarter to $750M.
Based on John G. Ullman & Associates's 13F filing for Q4 2025, filed 5 Feb 2026.